Your session is about to expire
← Back to Search
Intravaginal Devices for Urinary Incontinence
Study Summary
This trial found that 1 in 5 women experience urine leakage while exercising. Exercise is important and it's recommended to look for alternatives to manage this condition to maintain physical and mental health.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a diagnosed neurological condition like stroke or MS.You have been pregnant or given birth in the past year.I often leak urine when running but rarely at other times.I have had surgery on my urinary or genital organs.I experience severe pain during sexual intercourse, preventing me from undergoing a regular gynecological exam.I am a woman over 18 who runs 5 km in under 50 minutes, twice a week for a year.I am experiencing pain or have a muscle or bone injury currently.I experience symptoms related to the female athlete triad.You have any health issues that can make exercising risky.
- Group 1: Pessary Intervention
- Group 2: Control Group
- Group 3: Tampon Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are interested participants still eligible to join this trial?
"Data found on clinicaltrials.gov indicates this trial is not actively recruiting patients right now, as it was first posted on March 21st 2023 and last edited on March 6th 2023. However, 151 alternative studies have open recruitment periods currently."
What are the projected outcomes of this clinical experiment?
"The purpose of this 12-week clinical trial is to investigate weight gain, with secondary objectives being to observe any potential adverse events through weekly e-mail contact and follow up telephone calls. Ultrasound imaging will also be employed before and after a 30 minute running protocol on a treadmill in order to measure changes in bladder neck height and levator hiatus area."
Share this study with friends
Copy Link
Messenger